Unique Ingredient Identifier A2I8C7HI9T is listed as a ingredient substance
RN | 99-76-3 |
EC | 202-785-7 |
NCIT | C76720 |
RXCUI | 29903 |
PUBCHEM | 7456 |
MF | C8H8O3 |
INCHI KEY | LXCFILQKKLGQFO-UHFFFAOYSA-N |
SMILES | COC(=O)C1=CC=C(O)C=C1 |
UNII A2I8C7HI9T METHYLPARABEN is commonly included in medications in the following forms.
Route | Dosage Form | Potency |
---|---|---|
AN,INFILTRATION | INJECTION | 0.1 % |
AURICULAR (OTIC) | SUSPENSION | 0.001 % |
BUCCAL | FILM | 1 MG |
BUCCAL | FILM, SOLUBLE | 0.71 MG |
CAUDAL BLOCK | INJECTION | 0.1 % |
EPIDURAL | INJECTION | 0.1 % |
EPIDURAL | LIQUID, WATER, STERILE, FOR INJECTION | 5 % |
IM - IV | INJECTABLE | 0.12 % |
IM - IV | INJECTION | 0.75 % |
IM - IV | POWDER, FOR INJECTION SOLUTION | 0.36 % |
IM - IV | SOLUTION | 0.13 % |
IM - IV - SC | INJECTION | 0.44 % |
IM - SC | INJECTION | 0.18 % |
INFILTRATION | INJECTION | 1 MG/1ML |
INFILTRATION | INJECTION | 0.1 % |
INHALATION | SOLUTION | 2750 MG/INH |
INTRA-ARTERIAL | INJECTION | NA |
INTRA-ARTICULAR | INJECTION | 0.24 % |
INTRABURSAL | INJECTION | 0.18 % |
INTRADERMAL | INJECTION | 0.1 % |
INTRALESIONAL | INJECTION | 0.15 % |
INTRAMUSCULAR | INJECTABLE | 0.18 %W/V |
INTRAMUSCULAR | INJECTION | 1 MG/1ML |
INTRAMUSCULAR | INJECTION | 0.38 %W/V |
INTRAMUSCULAR | INJECTION, SOLUTION | 1.8 MG/1ML |
INTRAMUSCULAR | INJECTION, SUSPENSION | 0.14 % |
INTRAMUSCULAR | SOLUTION, INJECTION | NA |
INTRAMUSCULAR | SUSPENSION | 0.18 % |
INTRAMUSCULAR | SUSPENSION, INJECTION | 1.37 MG/1ML |
INTRAMUSCULAR | SUSPENSION, INJECTION | 0.14 %W/V |
INTRASYNOVIAL | INJECTION | NA |
INTRATUMOR | INJECTION | 0.08 % |
INTRAVASCULAR | INJECTION | 0.1 % |
INTRAVENOUS | INJECTABLE | 0.72 % |
INTRAVENOUS | INJECTION | 1 MG/1ML |
INTRAVENOUS | INJECTION | 0.75 % |
INTRAVENOUS | INJECTION, SOLUTION | 1.8 MG/1ML |
INTRAVENOUS | LIQUID, WATER, STERILE, FOR INJECTION | 0.18 % |
INTRAVENOUS | POWDER, FOR INJECTION SOLUTION | 1.5 % |
INTRAVENOUS | SOLUTION, INJECTION | 0.18 % |
INTRAVENOUS INFUSION | INJECTION | 1.8 MG/1ML |
IONTOPHORESIS | SOLUTION | 0.1 % |
IRRIGATION | SOLUTION | 2 % |
IV - SC | INJECTION | 1.5 MG/1ML |
IV - SC | INJECTION | 0.18 % |
IV(INFUSION) | INJECTION | 0.44 % |
IV(INFUSION) | LIQUID, WATER, STERILE, FOR INJECTION | 5 % |
IV(INFUSION) | POWDER, FOR INJECTION SOLUTION | 0.36 % |
NASAL | SOLUTION | 0.033 % |
NASAL | SPRAY, METERED | 0.7 % |
NERVE BLOCK | INJECTION | 1 MG/1ML |
NERVE BLOCK | INJECTION | 0.1 % |
OPHTHALMIC | OINTMENT | 0.05 % |
OPHTHALMIC | SOLUTION | 0.05 % |
OPHTHALMIC | SOLUTION, DROPS | 0.053 % |
OPHTHALMIC | SUSPENSION | 0.05 % |
OPHTHALMIC | SUSPENSION, DROPS | 0.05 % |
ORAL | CAPSULE | 1 MG |
ORAL | CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN, PERL | 0.32 MG |
ORAL | CAPSULE, COATED, SOFT GELATIN | 0.21 MG |
ORAL | CAPSULE, HARD GELATIN | NA |
ORAL | CAPSULE, SOFT GELATIN | 0.68 MG |
ORAL | CAPSULE, SUSTAINED ACTION | 0.86 MG |
ORAL | CONCENTRATE | 2 MG/1ML |
ORAL | DROPS | NA |
ORAL | EMULSION | NA |
ORAL | GRANULE | 50 MG |
ORAL | LIQUID | 10.13 mg/10mL |
ORAL | LIQUID | 2 MG |
ORAL | POWDER | 0.16 % |
ORAL | POWDER, FOR ORAL SOLUTION | 1.51 MG |
ORAL | POWDER, FOR ORAL SUSPENSION | 0.38 %W/W |
ORAL | POWDER, FOR SOLUTION | 1.58 MG/1ML |
ORAL | POWDER, FOR SUSPENSION | 5 MG/5ML |
ORAL | SOLUTION | 15 MG |
ORAL | SOLUTION | 12 mg/15 mL |
ORAL | SOLUTION | 2 MG/ML |
ORAL | SOLUTION, CONCENTRATE | 1 MG/1ML |
ORAL | SOLUTION, ELIXIR | 9 MG/5ML |
ORAL | SOLUTION, LIQUID | 2 MG/1ML |
ORAL | SOLUTION, SYRUP | 9 MG/5ML |
ORAL | SUSPENSION | 1000 MG/5ML |
ORAL | SUSPENSION | 6.6 MG/15ML |
ORAL | SUSPENSION | 2.12 mg/1mL |
ORAL | SUSPENSION, EXTENDED RELEASE | 10 MG/5ML |
ORAL | SUSPENSION, EXTENDED RELEASE | 1.8 MG/1ML |
ORAL | SUSPENSION, LIQUID | 10 MG/5ML |
ORAL | SUSPENSION, SUSTAINED ACTION | 7.5 MG/5ML |
ORAL | TABLET | 1.8 MG |
ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | 1.27 MG |
ORAL | TABLET, COATED | 0.016 MG |
ORAL | TABLET, CONTROLLED RELEASE | 0.081 MG |
ORAL | TABLET, FILM COATED | 0.23 MG |
ORAL | TABLET, SUSTAINED ACTION | 0.17 MG |
ORAL | TABLET, SUSTAINED ACTION, COATED | NA |
PARENTERAL | INJECTION | 0.18 % |
PARENTERAL | LIQUID, WATER, STERILE, FOR INJECTION | 5 % |
PERIDURAL | INJECTION | 0.1 % |
RECTAL | AEROSOL, METERED | 0.09 % |
RECTAL | ENEMA | 0.18 % |
RECTAL | LIQUID | 0.13 % |
RECTAL | SOLUTION | 0.13 % |
RECTAL | SUSPENSION | 0.23 % |
SOFT TISSUE | INJECTION | 0.15 % |
SUBCUTANEOUS | INJECTION | 0.3 % |
SUBCUTANEOUS | SUSPENSION, INJECTION | 0.25 % |
TOPICAL | CREAM | 0.2 %W/W |
TOPICAL | CREAM, AUGMENTED | 0.2 %W/W |
TOPICAL | CREAM, EMULSION, SUSTAINED RELEASE | 0.2 %W/W |
TOPICAL | EMULSION | 0.2 %W/W |
TOPICAL | EMULSION, AEROSOL FOAM | 0.11 %W/W |
TOPICAL | EMULSION, CREAM | 0.5 %W/W |
TOPICAL | EMULSION, LOTION | 0.17 %W/W |
TOPICAL | FILM, CONTROLLED RELEASE | 14 MG |
TOPICAL | GEL | 0.3 %W/W |
TOPICAL | JELLY | 0.07 %W/V |
TOPICAL | LOTION | 0.3 %W/W |
TOPICAL | OINTMENT | 0.2 %W/W |
TOPICAL | PATCH | NA |
TOPICAL | PATCH, CONTROLLED RELEASE | NA |
TOPICAL | SHAMPOO | 0.15 %W/W |
TOPICAL | SHAMPOO, SUSPENSION | 0.15 %W/W |
TOPICAL | SOLUTION | 0.1 %W/W |
TOPICAL | SPRAY | 0.2 %W/W |
TOPICAL | SUSPENSION | 0.3 %W/W |
URETERAL | SOLUTION | NA |
URETHRAL | INJECTION | 0.18 % |
URETHRAL | JELLY | 0.07 % |
VAGINAL | CREAM | 0.2 %W/W |
VAGINAL | CREAM, EMULSION, SUSTAINED RELEASE | 0.18 % |
VAGINAL | EMULSION, AEROSOL FOAM | 0.1 % |
VAGINAL | EMULSION, CREAM | 0.2 % |
VAGINAL | GEL | 0.08 % |
VAGINAL | SUPPOSITORY | NA |